Preoperative arterial interventional chemotherapy on cervical cancer
暂无分享,去创建一个
[1] H. Ayatollahi,et al. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] C. Kosloff,et al. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. , 1989, Gynecologic oncology.
[3] R. Alvarez,et al. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. , 1995, Gynecologic oncology.
[4] Y. Soong,et al. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma , 2004, Cancer Chemotherapy and Pharmacology.
[5] S. Hsueh,et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. , 1997, Gynecologic oncology.
[6] W. Creasman,et al. New gynecologic cancer staging. , 1990, Gynecologic oncology.
[7] Detection of disseminated tumor cells in patients with cervical cancer , 2002, Journal of Cancer Research and Clinical Oncology.
[8] G. Scambia,et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival , 1991, Cancer.
[9] Y. Moon,et al. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. , 2001, Gynecologic oncology.